secwatch.observer — SEC 8-K summary
======================================

Issuer:     VIVOS INC (RDGL)
CIK:        0001449349
Form:       8-K
Filed at:   2025-09-18T23:59:59+00:00
Accession:  0001493152-25-014047
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Inc. creates wholly owned India subsidiary for manufacturing and therapies
--------------------------------------------------------------------------------

- Board approved creation of Vivos Scientific India LLP on September 17, 2025.
- Entity is wholly owned, aims to establish manufacturing center in India.
- Objective includes expanding human therapies and commercialization in India.
- Will generate additional human trial data to support FDA approval process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1449349/000149315225014047/0001493152-25-014047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1449349/000149315225014047/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-014047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer